Private EquityRIA · CRD 281620SEC-RegisteredPrivate Fund Adviser

Updated:

Silversmith Capital Partners

Silversmith Capital Partners is a Boston growth equity firm writing $20M-$125M checks into capital-efficient tech and healthcare companies.

Silversmith Capital Partners logo

Silversmith Capital Partners

Silversmith Capital Partners is an SEC-registered investment adviser in Boston, MA, registered since 2017. The firm manages approximately $7.2 billion in regulatory assets. It has 38 employees and 38 investment advisers.

General information

Firm type

Private Equity

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Principals

Jeff Crisan

Managing Partner

Todd MacLean

Managing Partner

Jim Quagliaroli

Managing Partner

Sri Rao

Managing Partner

Lori Whelan

Managing Partner & COO

Brian Peterson

General Partner

Sector focus

Enterprise SoftwareHealthcare IT & ServicesSaaS & Information Services

Frequently asked questions

Who makes investment decisions at Silversmith Capital Partners?

All investment decisions are made collectively by the entire partnership. The firm operates without a traditional hierarchy in deal approval — every Managing Partner, the General Partner, and relevant Principals participate in evaluating and voting on each investment. This structure is designed to ensure that every portfolio company benefits from the full senior team's experience, not a single partner's coverage.

How does Silversmith source its deals?

Silversmith relies primarily on its network of entrepreneurs, operating partners, and senior advisors. The firm's 14 senior advisors include former C-suite executives from companies like Atlassian, HubSpot, and SurveyMonkey, providing a pipeline of referrals from within the technology ecosystem. The firm does not publicly disclose a dedicated business-development team, indicating a relationship-driven sourcing model.

What stage and check size does Silversmith target?

Silversmith writes growth equity checks between $20 million and $125 million. The firm targets companies that have achieved initial product-market fit, with at least $10 million in revenue, more than 20 percent year-over-year growth, and a demonstrated path to profitability. This places Silversmith squarely in the late-stage growth equity bracket, distinct from early-stage venture and large-cap buyout firms.

Does Silversmith lead rounds or participate alongside other investors?

Silversmith typically seeks to lead or co-lead growth rounds and takes significant minority or control positions depending on the founder's objectives. The firm emphasizes that it does not impose a standard operating playbook — portfolio company support in talent, technology, and M&A is available but structured as optional, on-demand resources rather than mandatory intervention.

What is Silversmith's relationship with its portfolio companies post-investment?

Silversmith embeds operational support directly into its partnership structure through dedicated Operating Partners focused on talent, technology (CTO), and go-to-market operations. These partners function as available advisors rather than prescriptive managers, allowing founders to pull in expertise when needed. The firm reports an 89 percent founder retention rate across its portfolio, which it attributes to this collaborative engagement model.

What sectors does Silversmith avoid?

Silversmith explicitly focuses on SaaS, Information Services, and Healthcare IT & Services. It does not invest in biotechnology, medical devices, hardware, or consumer brands. The firm states that specialization is central to its strategy and avoids sectors where it cannot bring deep domain expertise to the founder conversation.

What is the size of Silversmith's latest fund?

Silversmith closed its fifth fund, Silversmith Capital Partners V, at $1.7 billion in 2023. This represents a step-up in scale from prior fundraises and reflects increasing institutional demand for exposure to growth-stage technology and healthcare companies through a partnership-driven investment model.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Boston Private Equity profiles